
    
      This is a longitudinal double-blind 12-week study of the clinical and biochemical response to
      clozapine or chlorpromazine in a group of treatment-refractory schizophrenic patients.

      The study has 4 phases: (1) A recruitment period; (2) a period of discontinuation of
      psychotropic medication; (3) a drug-washout period; and (4) a 12-week double-blind trial of
      clozapine or chlorpromazine.
    
  